Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonistsJohn M Fevig, Jianxin Feng, Karen A Rossi, et al.Bioorganic & Medicinal Chemistry Letters|December 22, 2009
Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agentsSaleem Ahmad, Khehyong Ngu, Keith J Miller, et al.The Journal of Innovations in Cardiac Rhythm Management|September 28, 2020
The Grand SANS FLUORO (SAy No Series to FLUOROsopy) Study: Examining Fluoroscopy Use in More than 1,000 Ablation ProceduresRobert L Percell, Jonathan L Pike, Rhonda K Olmsted, et al.Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT(2C) receptor agonistsGuohua Zhao, Chet Kwon, Sharon N Bisaha, et al.Journal of Medicinal Chemistry|February 24, 2007
Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptorDean A Wacker, Jeffrey G Varnes, Sarah E Malmstrom, et al.Journal of Medicinal Chemistry|November 5, 2013
Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic propertiesBruce A Ellsworth, Philip M Sher, Ximao Wu, et al.Journal of Medicinal Chemistry|October 6, 2021
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic DisordersHuji Turdi, Hannguang Chao, Jon J Hangeland, et al.Pageof 5